World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
117
Citations
85278
World Ranking
4109
National Ranking
40

Richard Sylvester publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Richard Sylvester sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 559 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Richard Sylvester D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Sylvester sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 117 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Richard Sylvester is affiliated with the European Organisation for Research and Treatment of Cancer in Belgium. Their research primarily focuses on medicine, with a significant concentration in surgery, neurology, epidemiology, oncology, and urology. The main topics of their work include bladder and urothelial cancer treatments, urinary and genital oncology studies, esophageal cancer research and treatment, traumatic brain injury research, urological disorders and treatments, traumatic brain injury and neurovascular disturbances, and colorectal cancer screening and detection.

Their recent scholarly contributions include publications in peer-reviewed journals such as European Urology, European Urology Oncology, and Brain. Notable papers are:

  • European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ), 2021, European Urology
  • European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update, 2020, European Urology
  • European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel, 2021, European Urology
  • Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study, 2021, European Urology Oncology
  • COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database, 2022, Brain

Frequent coauthors collaborating with Sylvester include:

  • Paolo Gontero
  • Joan Palou
  • Morgan Rouprêt
  • Shahrokh F. Shariat
  • Éva Compérat

Their work appears predominantly in the following publication venues:

  • European Urology
  • European Urology Oncology
  • Brain
  • Journal of Neurology Neurosurgery & Psychiatry
  • The Journal of Urology

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

    Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett

  • Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

    Richard J. Sylvester;Adrian P.M. van der Meijden;Willem Oosterlinck;J. Alfred Witjes

  • EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

    Marko Babjuk;Andreas Böhle;Maximilian Burger;Otakar Capoun

  • Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

    G H J Mickisch;A Garin;H van Poppel;L de Prijck

  • Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial

    Joop A. van Dongen;Adri C. Voogd;Ian S. Fentiman;Catherine Legrand

  • International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers

    GM Mead;SP Stenning;P Cook;SD Fossa

  • EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

    Marko Babjuk;Maximilian Burger;Richard Zigeuner;Shahrokh F. Shariat

  • [EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update].

    M. Babjuk;W. Oosterlinck;R. Sylvester;E. Kaasinen

  • Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

    Jean Bourhis;Jens Overgaard;Helene Audry;Kian K. Ang

  • European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

    Morgan Rouprêt;Marko Babjuk;Eva Compérat;Richard Zigeuner

  • Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma

    Francesco Pignatti;Martin van den Bent;Desmond Curran;Channa Debruyne

  • European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.

    Marko Babjuk;Marko Babjuk;Maximilian Burger;Eva M. Compérat;Paolo Gontero

  • International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

    Gareth Griffiths;Reginald Hall;Richard Sylvester;Derek Raghavan

  • Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials

    O Dalesio;H van Tinteren;M Clarke;R Peto

  • Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data

    JF Tierney;Richard J. Sylvester

  • A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma

    Hendrik Van Poppel;Luigi Da Pozzo;Walter Albrecht;Vsevolod Matveev

  • European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).

    Marko Babjuk;Marko Babjuk;Maximilian Burger;Otakar Capoun;Daniel Cohen

  • EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

    Marko Babjuk;Willem Oosterlinck;Richard Sylvester;Eero Kaasinen

  • Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986

    Maria De Santis;Joaquim Bellmunt;Graham Mead;J. Martijn Kerst

Frequent Co-Authors

Laurence Collette
Laurence Collette European Organisation for Research and Treatment of Cancer
Sophie D. Fosså
Sophie D. Fosså Oslo University Hospital
Stefan Suciu
Stefan Suciu European Organisation for Research and Treatment of Cancer
Armando Santoro
Armando Santoro Humanitas University
J. Alfred Witjes
J. Alfred Witjes Radboud University
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna
Guido Dalbagni
Guido Dalbagni Memorial Sloan Kettering Cancer Center
Steven Joniau
Steven Joniau KU Leuven

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

There are numerous alternative pathways for those interested in healthcare professions beyond a traditional medical degree. For example, adn nursing programs offer a practical route to becoming a registered nurse in a shorter timeframe, often with flexible admission requirements.

If direct patient care isn’t your preference, consider options like medical billing and coding schools online with financial aid. These programs can be completed remotely and prepare graduates for vital administrative roles in healthcare, often with financial assistance available.

Accelerated and streamlined nursing tracks are available, too. Some students opt for an lpn program without teas test requirements, making entry into nursing even more accessible.

Lastly, for those interested in leadership, an administrative path—like pursuing the best online healthcare administration degree—equips graduates to manage teams and healthcare systems. Exploring these related degrees can expand your career options within the healthcare field.

Best Scientists Citing Richard Sylvester

Trending Scientists

Recently Published Articles